The Named Patient Programs (NPP) are import regimes that allow
medicines not authorized in Türkiye or authorized but
unavailable for various reasons to be imported from abroad upon
request by a physician.
Following publication of the Regulation on the Importation of
Medicines from Abroad ("NPP Regulation") published on 3
February 2023, the roles of stakeholders in the relevant process
have been clarified. According to this NPP Regulation, institutions
and organisations located abroad have been defined as "Foreign
Drug Supply Sources," and it has become mandatory for them to
have a representative in Türkiye.
Furthermore, institutions approved by the Turkish Pharmacists'
Association, SSI, and the Ministry of Health have been designated
as "Foreign Drug Suppliers," and it has
been stipulated that pharmaceutical warehouses must distribute
medicines in compliance with the relevant regulations.
